Loading news...
Crescent Capital BDC, Inc. (NASDAQ: CCAP - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the six ratings firms that are currently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has given a strong buy
Crescent Capital BDC and VICI Properties offer a barbell approach to income investing across interest rate cycles. CCAP provides a 13.1% yield, trades at a 33% discount to NAV, and maintains a conservative, first-lien, floating-rate loan portfolio. VICI delivers a 6.3% yield, robust AFFO growth, and long-term revenue stability via triple-net leases on premier gaming and experiential properties.
After losing some value lately, a hammer chart pattern has been formed for Crescent Capital BDC (CCAP), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Crescent Capital BDC (CCAP) offers a 13% yield and trades at a discount to NAV, but portfolio quality has eroded, with rising non-accruals and watchlist investments. CCAP's portfolio is concentrated in healthcare and software, with 99% sponsor-backed, first lien senior secured loans, but sector and credit risk are elevated, versus peers. Dividend coverage remains solid, supported by spillover income, yet management is reassessing the dividend and structure, with an update expected next quarter.
Crescent Capital BDC (CCAP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Crescent Capital BDC (CCAP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Crescent Capital BDC, Inc. trades at a 0.66x P/NAV, reflecting a ~34% discount and a 13.4% dividend yield. CCAP's fundamentals remain robust: 107% dividend coverage, conservative 40% portfolio LTV, and 2.2x interest coverage, despite a slight non-accrual uptick. A potential base dividend cut looms due to lower SOFR, but even a 20% reduction would leave a ~10.7% yield and stable NAV outlook.
Crescent Capital BDC (NASDAQ: CCAP) reported fourth-quarter net investment income (NII) of $0.45 per share, down slightly from $0.46 in the prior quarter, as lower reference rates weighed on interest income. Management said results again exceeded the quarterly dividend, and the board declared a regular quarterly cash dividend of $0.42 per share for the first quarter
Crescent Capital BDC, Inc. (CCAP) Q4 2025 Earnings Call Transcript
LOS ANGELES, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $1.81 per share and net income of $0.93 per share for the year ended December 31, 2025. For the quarter ended December 31, 2025, net investment income and net income per share were $0.45 and $0.23, respectively. Reported net asset value (NAV) per share was $19.10 at December 31, 2025. The Company announced that its Board of Directors (the “Board”) declared a first quarter 2026 regular cash dividend of $0.42 per share to stockholders of record as of March 31, 2026, payable on April 15, 2026.
Shares of Crescent Capital BDC, Inc. (NASDAQ: CCAP - Get Free Report) have earned an average rating of "Moderate Buy" from the six ratings firms that are currently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued
Main Street Capital (NYSE: MAIN - Get Free Report) and Crescent Capital BDC (NASDAQ: CCAP - Get Free Report) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, dividends, risk and institutional ownership. Volatility and Risk Main Street Capital
Crescent Capital BDC (NASDAQ: CCAP - Get Free Report) and Nuveen Churchill Direct Lending (NYSE: NCDL - Get Free Report) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, valuation, profitability and dividends. Analyst Ratings This is
LOS ANGELES, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (the “Company”) (NASDAQ: CCAP) today announced that it has rescheduled the release of its financial results and accompanying earnings webcast/conference call for the fourth quarter and fiscal year ended December 31, 2025. The Company will now release its financial results for the fourth quarter and fiscal year ended December 31, 2025 on Wednesday, February 25, 2026 after market close and host a webcast/conference call on Thursday, February 26, 2026 at 12:00 p.m. Eastern Time.
My income portfolio prioritizes resilient, high-dividend securities with long-term positive NAV trends rather than trading based on unpredictable short-term price movements. Therefore, I focus on funds that have demonstrated value creation since launch, especially those with at least a decade of performance history, with its accompanying ups and downs. In this article, I show how the NAVs of all my securities behaved during the worst moments of their existence and how they largely rebounded.
LOS ANGELES, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the fourth quarter and fiscal year ended December 31, 2025 on Wednesday, February 18, 2026 after market close. Crescent BDC invites all interested persons to attend its webcast/conference call on Thursday, February 19, 2026 at 12:00 p.m. Eastern Time to discuss its fourth quarter and year ended December 31, 2025 financial results.
2 BDC Value Creators For Durable NAV And High Income
Crescent Capital BDC: Deep-Value And 12%+ Yielding Case To Buy
Most BDC investors are value investors, who focus on income. The higher the multiple, the lower the yield - i.e., a mechanic that leads "bargain hunters" underemphasizing high P/NAV BDCs. In the article I detail why this kind of approach might be suboptimal.
I focus on business development companies, or BDCs, with durable dividends, strong downside protection, and resilience to rate and credit risk shifts. However, there is also a merit of including BDCs, which would qualify for tactical investment bucket - i.e., high risk, high return. In the article I outline the rationale of having such exposures and provide two practical examples, which carry high potential to beef up the total return component.